CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 1st Interim Announcement

DGAP Post-admission Duties announcement: CompuGroup Medical SE & Co. KGaA / Share Buy-Back CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 1st Interim Announcement 06.12.2021 / 13:27 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Disclosure pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 1st Interim Announcement In the period from November 26, 2021 until and including December 3, 2021, CompuGroup Medical SE & Co. KGaA has bought back an aggregate number of 78,221 shares in CompuGroup Medical SE & Co. KGaA within its share buy-back program which had been announced on November 25, 2021 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start on November 26, 2021. The aggregate number of shares bought back each day during the period from November 26, 2021 until and including December 3, 2021 as well as the daily volume-weighted average prices for such buy-backs are as follows: Date Aggregate volume (number of no-par value shares) Volume-weighted average price (in EUR, excluding ancillary costs and charges) November 26, 2021 12,774 68.4069 November 29, 2021 12,140 68.2422 November 30, 2021 12,772 68.6506 December 1, 2021 13,156 67.4449 December 2, 2021 13,241 67.2937 December 3, 2021 14,138 66.9564 Total: 78,221 67.8325   The aggregate number of shares bought back within the share buy-back program in the period from November 26, 2021 until and including December 3, 2021 amounts to 78,221 shares. Detailed information about the transactions are published on the company's website under www.cgm.com/sbb. The acquisitions of the shares in CompuGroup Medical SE & Co. KGaA were carried out by a credit institution assigned by CompuGroup Medical SE & Co. KGaA exclusively via the Frankfurt Stock Exchange (XETRA trading). Koblenz, December 6, 2021 CompuGroup Medical SE & Co. KGaA The general partner 06.12.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	CompuGroup Medical SE & Co. KGaA
	Maria Trost 21
	56070 Koblenz
	Germany
Internet:	www.cgm.com

End of News	DGAP News Service

1254478  06.12.2021